VIRTUOZO

Welcome to the Brand page for “VIRTUOZO”, which is offered here for In the statement, page 1, lines 13-14, medical diagnostic preparations for medical purposes, reagents for medical use, diagnostic agents preparations and substances for medical purposes should be deleted, and none of the aforementioned products in the vitro diagnostic and theranostic fields. should be inserted.;vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, huntington's disease and disorder, insomnia, parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, adhd, oncology, pain, alcoholism and dependency; none of the aforementioned products in the vitro diagnostic and theranostic fields;.

Its status is currently believed to be active. Its class is unavailable. “VIRTUOZO” is believed to be currently owned by “H. Lundbeck A/S”.

Owner:
H. LUNDBECK A/S
Owner Details
Description:
In the statement, Page 1, lines 13-14, medical diagnostic preparations for medical purposes, reagents for medical use, diagnostic agents preparations and substances for medical purposes should be deleted, and none of the aforementioned products in the vitro diagnostic and theranostic fields. should be inserted.;Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; none of the aforementioned products in the vitro diagnostic and theranostic fields;
Categories: STATEMENT